1900 1717 
PSA is a protein made by the prostate, part of the male reproductive system. Most PSA in the blood is bound to serum proteins. A small amount is not protein-bound and is called free PSA. In men with prostate cancer, the ratio of free (unbound) PSA to total PSA is decreased. The lower the ratio, the greater the probability of prostate cancer.
352,000 đ
PSA is a protein your prostate produces. Most PSA in the blood is bound to serum proteins. A small amount is not protein bound and is called free PSA. In men with prostate cancer, the ratio of free (unbound) PSA to total PSA is decreased. The lower the ratio, the greater the probability of prostate cancer.
189,000 đ
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder affecting red blood cells, which carry oxygen from the lungs to tissues throughout the body. The disease can cause hemolysis, where red blood cells are destroyed faster than the body can replace them.
180,000 đ
Lung cancer includes small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). Only about 15% of lung cancers are SCLC. Pro-GRP is sensitive to SCLC diagnosis. High marker levels are related to a high disease burden.
399,000 đ
Prothrombin is a protein from your liver that acts as a clotting (coagulation) factor. If your blood clots too slowly, you may bleed excessively after an injury. If your blood clots too fast, the clots may harm your heart or brain. A prothrombin time (PT) test measures how long it takes for a clot to form.
60,000 đ
Squamous cell carcinoma (SCC) of the skin is the second most common skin cancer, characterized by abnormal, accelerated cellular growth. This cancer begins in squamous cells, found in the tissue that forms the skin's surface and the passages of the respiratory and digestive tracts. This test helps evaluate and monitor squamous cell carcinoma of the head, neck, lung, and cervix.
275,000 đ
PSA is a protein made by your prostate, a gland in the male reproductive system. The test is used to screen for prostate cancer. Cancer screening means looking for signs of cancer before symptoms appear. But screening tests can't diagnose cancer. If a screening test finds signs of cancer, you'll need other tests to determine if you have cancer and how serious it may be.
